Skip to main content
Marksans Pharma Ltd. logo

Marksans Pharma Ltd. — Investor Relations & Filings

Ticker · MARKSANS ISIN · INE750C01026 LEI · 335800YXQPMPSAC51K30 BSE.NS Manufacturing
Open in API
Filings indexed 755 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country IN India
Listing BSE.NS MARKSANS

About Marksans Pharma Ltd.

https://www.marksanspharma.com

Marksans Pharma Ltd. specializes in the research, development, and large-scale manufacturing of generic formulations. The company’s therapeutic focus spans pain management, cardiovascular health, central nervous system disorders, anti-diabetics, and gastrointestinal treatments. Its product portfolio includes diverse delivery systems such as solid orals, soft gelatin capsules, and liquid formulations, serving both the over-the-counter and prescription markets. The organization operates advanced manufacturing facilities compliant with international regulatory standards, facilitating a robust supply chain across major global markets including North America, Europe, and Australia. By integrating comprehensive research and development with efficient production processes, the company provides a broad range of high-quality, cost-effective medicinal products to a global patient base.

Recent filings

Filing Released Lang Actions
India Ratings and Research has revised the outlook for the Company''s bank loan facilities to Positive from Stable
Regulatory Filings Classification · 87% confidence The document is an intimation under Regulation 30 of SEBI Listing Obligations regarding a credit rating outlook revision by a ratings agency. It is a regulatory announcement to stock exchanges rather than a financial report, board change, or capital raising. It does not contain substantive financial statements or presentations. Therefore, it falls under general regulatory filings (RNS).
2026-06-09 English
Credit Rating- Revision
Regulatory Filings Classification · 78% confidence The document is a letter to BSE and NSE under SEBI LODR Regulation 30 disclosing a credit rating outlook revision. It does not contain financial statements or actual financing transactions; it is a regulatory announcement. There is no specific category for credit rating notifications, so it falls under general Regulatory Filings (RNS).
2026-06-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 88% confidence The document is a short intimation to stock exchanges under SEBI Listing Obligations, notifying the schedule of a virtual investor conference. It contains no financial data or presentation materials, nor is it a transcript or report. This is a general regulatory disclosure. According to the definitions and the MENU vs MEAL rule, it should be classified as a Regulatory Filing (RNS).
2026-06-08 English
Intimation of schedule for Virtual Investors Conference
Regulatory Filings Classification · 82% confidence The document is an intimation under SEBI Listing Obligations (Regulation 30) notifying stock exchanges about the company’s participation in a virtual investor conference. It contains no financial results, report attachments, management changes, or capital actions. It is a routine regulatory announcement to the exchange, so it falls under general regulatory filings.
2026-06-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is titled “Transcript of investor(s)/analyst(s) meet – Q4 FY26 Audited Financial Results” and contains the full text of an earnings conference call (moderator introduction, management remarks, and Q&A). This matches the definition of a Call Transcript (CT).
2026-06-03 English
Marksans Pharma Limited submits Transcripts of Investors/Analyst meet on Q4 FY 26 Audited Financial Results
Call Transcript Classification · 93% confidence The document is a full text transcript of the Marksans Pharma Q4 FY26 earnings conference call, including moderator introduction, management remarks, financial metrics discussion, and Q&A. This matches the definition of a Call Transcript (CT).
2026-06-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.